After it was confirmed that both the mRNA and protein levels of PHD3 and FIH were obviously reduced in tumor tissue, we were notably interested in whether these changes had any correlation with the clinicopathological features of HCC patients. Here, CASR is linked to hepatocellular carcinoma.